Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SGLT2 inhibition attenuates arterial dysfunction and decreases vascular F-actin content and expression of proteins associated with oxidative stress in aged mice
Rogério N. Soares, Francisco I. Ramirez‐Perez, Francisco J. Cabral-Amador, et al.
GeroScience (2022) Vol. 44, Iss. 3, pp. 1657-1675
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress
Clara Luna-Marco, Francesca Iannantuoni, Alberto Hermo-Argibay, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 19-35
Open Access | Times Cited: 25
Endothelial Protection by Sodium-Glucose Cotransporter 2 Inhibitors: A Literature Review of In Vitro and In Vivo Studies
N Mylonas, Panagiota Nikolaou, Paschalis Karakasis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7274-7274
Open Access | Times Cited: 17
Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases
Cláudia Penna, Pasquale Pagliaro
Antioxidants (2025) Vol. 14, Iss. 3, pp. 256-256
Open Access | Times Cited: 2
Vascular stiffening and endothelial dysfunction in atherosclerosis
Aukie Hooglugt, Olivia C. Klatt, Stephan Huveneers
Current Opinion in Lipidology (2022) Vol. 33, Iss. 6, pp. 353-363
Open Access | Times Cited: 39
Arterial Stiffness and its Impact on Cardiovascular Health
Rachel Anne Xuereb, Caroline Jane Magri, Robert G. Xuereb
Current Cardiology Reports (2023) Vol. 25, Iss. 10, pp. 1337-1349
Closed Access | Times Cited: 25
SGLT2 inhibition ameliorates nano plastics-induced premature endothelial senescence and dysfunction
Bikalpa Dhakal, Saugat Shiwakoti, Eun‐Young Park, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging
Anna De Bartolo, Tommaso Angelone, Carmine Rocca
Vascular Pharmacology (2025), pp. 107462-107462
Closed Access | Times Cited: 1
Cardiovascular aging: from cellular and molecular changes to therapeutic interventions
Angeliki Vakka, Junco S. Warren, Konstantinos Drosatos
The Journal of Cardiovascular Aging (2023)
Open Access | Times Cited: 19
The effect of SGLT2 inhibitors on the endothelium and the microcirculation: from bench to bedside and beyond
Kyriakos Dimitriadis, Eleni Adamopoulou, Nikolaos Pyrpyris, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 8, pp. 741-757
Closed Access | Times Cited: 18
Heterogeneous treatment effects of sodium‐glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population‐based cohort study
Huilin Tang, William T. Donahoo, Mikael Svensson, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5528-5539
Open Access | Times Cited: 8
Impact of Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging—What Do We Know So Far? (A Narrative Review)
Cristina Andreea Adam, Răzvan Anghel, Dragoș Traian Marius Marcu, et al.
Life (2022) Vol. 12, Iss. 6, pp. 803-803
Open Access | Times Cited: 27
Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?
Rehma Siddiqui, Yoshitsugu Obi, Neville R. Dossabhoy, et al.
Current Hypertension Reports (2024) Vol. 26, Iss. 12, pp. 463-474
Open Access | Times Cited: 5
New insights into the molecular mechanisms of SGLT2 inhibitors on ventricular remodeling
Yang Chen, Daoquan Peng
International Immunopharmacology (2023) Vol. 118, pp. 110072-110072
Open Access | Times Cited: 12
The Influence of Empagliflozin on the Expression of Mitochondrial Regulatory Proteins in Human Myocardium in an Ex Vivo Model of Short-Term Atrial Tachypacing
Paweł Muszyński, Magdalena Cieślińska, Magdalena Dziemidowicz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1664-1664
Open Access
Small Arteries From Old Spontaneously Hypertensive Rats Exhibit Enhanced Endothelium‐Independent Vasodilatory Capacity and Reduced Stiffness
Francisco I. Ramirez‐Perez, Thomas J. Jurrissen, Marc A. Augenreich, et al.
Microcirculation (2025) Vol. 32, Iss. 2
Closed Access
Roadmap for alleviating the manifestations of ageing in the cardiovascular system
Luca Liberale, Simon Tual‐Chalot, Simon Sedej, et al.
Nature Reviews Cardiology (2025)
Closed Access
Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
Lin Mao, Ruili Yin, Longyan Yang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 17
Role of adropin in arterial stiffening associated with obesity and type 2 diabetes
Thomas J. Jurrissen, Francisco I. Ramirez‐Perez, Francisco J. Cabral-Amador, et al.
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 5, pp. H879-H891
Open Access | Times Cited: 17
Atomic force microscopy in disease‐related studies: Exploring tissue and cell mechanics
Shuaiyuan Liu, Yibo Han, Lingwen Kong, et al.
Microscopy Research and Technique (2023) Vol. 87, Iss. 4, pp. 660-684
Open Access | Times Cited: 10
Life’s Essential 8
Manish Kumar, Ariela R. Orkaby, Caitlan A. Tighe, et al.
JACC Advances (2023) Vol. 2, Iss. 7, pp. 100560-100560
Open Access | Times Cited: 9
SGLT2 inhibitor improves the prognosis of patients with coronary heart disease and prevents in-stent restenosis
Qing Zhang, Zhiwen Deng, Tudi Li, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 3
Empagliflozin decreases ageing-associated arterial stiffening and vascular fibrosis under normoglycemic conditions
Cédric Neutel, Callan D. Wesley, Melissa Van Praet, et al.
Vascular Pharmacology (2023) Vol. 152, pp. 107212-107212
Open Access | Times Cited: 7
Sitting leg vasculopathy: potential adaptations beyond the endothelium
Larissa Ferreira‐Santos, Luis A. Martinez‐Lemus, Jaume Padilla
AJP Heart and Circulatory Physiology (2024) Vol. 326, Iss. 3, pp. H760-H771
Closed Access | Times Cited: 2
Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance
Angelica Cersosimo, Nadia Salerno, Jolanda Sabatino, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Therapeutic strategies targeting the endothelial glycocalyx
Daniel R. Machin, Mostafa Sabouri, Xiangyu Zheng, et al.
Current Opinion in Clinical Nutrition & Metabolic Care (2023) Vol. 26, Iss. 6, pp. 543-550
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top